Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer. Hachey JS, Viray TD, Matasci M, Ravazza D, et al. J Nucl Med 2025 Apr 17:jnumed.124.268859. doi: 10.2967/jnumed.124.268859.

Read + Share

Amedeo Smart

Independent Medical Education

Hachey JS, Viray TD, Matasci M, Ravazza D, et al. Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer. J Nucl Med 2025 Apr 17:jnumed.124.268859. doi: 10.2967/jnumed.124.268859.
PMID: 40246542